The effect of intravenous dexamethasone in supraclavicular brachial plexus block at Halibet National Referral Hospital, Eritrea 2024-2025: A randomized clinical trial.
PLoS OneSep 3, 2026 (epub)
Michael Beraki Mengistu, Senay Amare Habtu, Abel Mussie Elias et al.
✦ AI-curated · Sources linked
In 30 seconds
This randomized clinical trial evaluated the effect of intravenous dexamethasone on postoperative analgesia in 60 patients undergoing upper limb surgery with supraclavicular brachial plexus block. The study found that the mean duration of analgesia was significantly longer in the dexamethasone group (17.36 ± 3.75 hours) compared to the control group (7.57 ± 1.04 hours, p < 0.001).
Key findings
- Mean duration of analgesia was 17.36 ± 3.75 hours in the dexamethasone group vs 7.57 ± 1.04 hours in the control group.
- Dexamethasone group experienced faster onset of sensory and motor block.
- Lower analgesic consumption was noted in the dexamethasone group.
Why it matters
Enhancing postoperative analgesia can significantly improve patient recovery and reduce healthcare costs. The use of adjuncts like dexamethasone may optimize pain management strategies, especially in resource-limited settings.